Literature DB >> 25907399

Presentation, diagnosis, and management of early hepatic venous outflow complications in whole cadaveric liver transplant.

Shirin Elizabeth Khorsandi1, Anuja Athale1, Hector Vilca-Melendez1, Wayel Jassem1, Andreas Prachalias1, Parthi Srinivasan1, Mohamed Rela1, Nigel Heaton1.   

Abstract

Early hepatic venous outflow obstruction (HVOO) can be a devastating complication leading to graft loss after liver transplantation (LT). A retrospective study on 777 adult LT recipients over a 5-year period (August 2007 to August 2012) was undertaken to determine the incidence of early HVOO presenting within 3 months of transplant, its clinical features and management, and potential technical risk factors related to the implanting technique. Cases of early HVOO were screened for by identifying recipients with problematic ascites within 3 months of transplant. Definitive diagnosis for HVOO was based on a wedge pressure of >12 mm Hg. Considering only whole livers, the incidence of early problematic ascites was 3% (20/695) of which more than one-third (35%, 7/20) were then confirmed to have HVOO. Overall, the incidence of early HVOO was 1% (7/695). Two hepatic veins (HVs) with extension piggybacks (PBs; n = 423) were the dominant implanting technique in the time period of study rather than the 3 HV PB (n = 182) and caval replacement techniques (n = 82). Considering the implantation technique, all cases of HVOO occurred after 2 HVs when extension PBs had been used with an incidence of 1.7% (7/423). Institutionally, early HVOO was mainly managed surgically by either cavoplasty within a month of transplant (n = 4) or retransplant (n = 1), and the remainder (n = 2) were medically managed with diuretics. In conclusion, early HVOO is rare, and there is no evidence from this study that a given implantation technique is at a higher risk of developing HVOO (2 HV with extension versus 3 HV and caval replacement; P = 0.11). However, early revisional surgery for HVOO can preserve graft function with retransplantation being reserved for when surgical cavoplasty or radiological stenting is technically not possible.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25907399     DOI: 10.1002/lt.24154

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

1.  Is Routine Intraoperative Contrast-Enhanced Ultrasonography Useful During Whole Liver Transplantation?

Authors:  Nicolas Golse; Simone Santoni; Vincent Karam; Oriana Ciacio; Gabriella Pittau; Marc-Antoine Allard; Daniel Cherqui; Antonio Sa Cunha; René Adam; Denis Castaing; Eric Vibert
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

2.  Management of Ascites Following Deceased Donor Liver Transplantation: A Case Series.

Authors:  Mohammad Al-Zoubi; Moath Alarabiyat; Angus Hann; Homoyon Mehrzhad; Salil Karkhanis; Paolo Muiesan; Manuel Abradelo; Hermien Hartog; Keith Roberts; Darius F Mirza; John R Isaac; Bobby V M Dasari
Journal:  Transplant Direct       Date:  2022-07-19

3.  Novel use of percutaneous thrombosuction to rescue the early thrombosis of the conduit vein graft after living donor liver transplantation.

Authors:  Kuo-Shyang Jeng; Chun-Chieh Huang; Hao-Yuan Tsai; Jung-Cheng Hsu; Cheng-Kuan Lin; Kuo-Hsin Chen
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-08-17

4.  Inferior Vena Cava Constriction After Liver Transplantation Is a Severe Complication Requiring Individually Adapted Treatment: Report of a Single-Center Experience.

Authors:  Jan-Paul Gundlach; Rainer Günther; Marcus Both; Jens Trentmann; Jost Philipp Schäfer; Jochen T Cremer; Christoph Röcken; Thomas Becker; Felix Braun; Alexander Bernsmeier
Journal:  Ann Transplant       Date:  2020-08-04       Impact factor: 1.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.